Dr Clarkson joins Agiomix with 20 years’ experience of developing commercial diagnostics and life science tools.

Agiomix, the next generation genomics company, has announced the appointment of Dr John Clarkson as chairman with immediate effect.

Dr Clarkson joins Agiomix with 20 years’ experience of developing commercial diagnostics and life science tools. He has held a number of senior commercial and technical leadership positions within both public and private companies.

Most recently, Dr Clarkson was the founding CEO of the molecular diagnostics company, Atlas Genetics, where he remains a non-executive director. During his tenure at Atlas Genetics, Dr Clarkson raised $90 million with multiple fundraising to fund the development of the rapid io diagnostic platform for infectious diseases from concept through to regulatory approval